Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells (Q39672456)

13 September 2017

Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells (English)

1 reference

13 September 2017

0 references

1 reference

H Y Choi

1

1 reference

PubMed ID

20680030

13 September 2017

J E Lim

series ordinal

2

1 reference

PubMed ID

20680030

13 September 2017

J H Hong

series ordinal

3

1 reference

PubMed ID

20680030

13 September 2017

language of work or name

1 reference

3 August 2010

1 reference

Prostate Cancer and Prostatic Diseases

13 September 2017

1 reference

13 September 2017

13

1 reference

13 September 2017

343-349

1 reference

13 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2010.26

13 September 2017

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Roles and regulation of Wnt signaling and beta-catenin in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Linking beta-catenin to androgen-signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Wnt/beta-catenin signaling: components, mechanisms, and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Beta-catenin signaling in prostate cancer: an early perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

GSK-3: tricks of the trade for a multi-tasking kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Wnt signalling and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Curcumin: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

The ubiquitin-proteasome pathway and its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Prostate cancer and curcumin: add spice to your life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.26

7 January 2021

inferred from DOI database lookup

Identifiers

1 reference

https://api.fatcat.wiki/v0/release/g4y3x7sturennnpdd65vlo4tly

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_g4y3x7sturennnpdd65vlo4tly

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g4y3x7sturennnpdd65vlo4tly

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/g4y3x7sturennnpdd65vlo4tly

30 July 2022